1 Min Read
July 20 (Reuters) - Urogen Pharma Ltd
* Jay Moorin reports a 11.5 percent passive stake in Urogen Pharma Ltd as of May 9, 2017 - SEC filing Source text for Eikon: (bit.ly/2ufDxWd) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.